Atara Biotherapeutics
ATRA
#8985
Rank
HK$0.60 B
Marketcap
HK$106.51
Share price
-4.00%
Change (1 day)
112.14%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2024 (TTM): HK$0.48 Billion

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.48 Billion. In 2023 the company made a revenue of HK$66.95 Million a decrease over the revenue in the year 2022 that were of HK$0.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$0.48 B628.43%
2023 HK$66.95 M-86.52%
2022 HK$0.49 B213.18%
2021 HK$0.15 B
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$1.24 B 155.87%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$22.29 M-95.41%๐Ÿ‡ฉ๐Ÿ‡ช Germany
HK$2.23 B 361.02%๐Ÿ‡บ๐Ÿ‡ธ USA